MYELOID MALIGNANCIES
Clinical trials for MYELOID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MYELOID MALIGNANCIES trials appear
Sign up with your email to follow new studies for MYELOID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Boosting transplants with natural killers: new combo aims to stop blood cancer return
Disease control CompletedThis phase 2 trial tested whether adding ready-made donor natural killer (NK) cells to a standard stem cell transplant could safely reduce the chance of cancer coming back in people with high-risk myeloid cancers like AML, MDS, and CML. Twenty-four patients received the combinati…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:48 UTC
-
New hope for tough blood cancers: experimental drug PRT2527 tested in early trial
Disease control CompletedThis early-stage study tested a new drug called PRT2527, alone or combined with other medicines (zanubrutinib or venetoclax), in 86 people with blood cancers that returned or didn't respond to standard treatments. The main goals were to check safety, find the best dose, and see i…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:05 UTC